Author:
Wilkerson Myra L.,Cheng Liang
Reference150 articles.
1. Wagner U, Sauter G, Moch H, et al. Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder. Hum Pathol. 1995;26(9):970–8.
2. Mallofre C, Castillo M, Morente V, Sole M. Immunohistochemical expression of CK20, p53, and ki-67 as objective markers of urothelial dysplasia. Mod Pathol. 2003;16(3):187–91.
3. Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H, Dimopoulos MA. The prevalence of bcl-2, p53, and ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum Pathol. 1998;29(2):146–54.
4. Southgate J, Harnden P, Trejdosiewicz LK. Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histol Histopathol. 1999;14(2):657–64.
5. McKenney JK, Desai S, Cohen C, Amin MB. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. Am J Surg Pathol. 2001;25(8):1074–8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bladder Pathology;Practical Genitourinary Pathology;2020-10-30